Formal goals may be on the way for generic drug sponsors who require meetings with FDA prior to submitting an ANDA, which has the potential to streamline the process for complex generics.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?